The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age.
- Published In:
- Kidney international, 91(5), 1126-1145 (2017)
- Authors:
- Sweetwyne, Mariya T, Pippin, Jeffrey W, Eng, Diana G, Hudkins, Kelly L, Chiao, Ying Ann, Campbell, Matthew D, Marcinek, David J, Alpers, Charles E, Szeto, Hazel H, Rabinovitch, Peter S, Shankland, Stuart J
- Database ID:
- RPEP-03487
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03487APA
Sweetwyne, Mariya T; Pippin, Jeffrey W; Eng, Diana G; Hudkins, Kelly L; Chiao, Ying Ann; Campbell, Matthew D; Marcinek, David J; Alpers, Charles E; Szeto, Hazel H; Rabinovitch, Peter S; Shankland, Stuart J. (2017). The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age.. Kidney international, 91(5), 1126-1145. https://doi.org/10.1016/j.kint.2016.10.036
MLA
Sweetwyne, Mariya T, et al. "The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age.." Kidney international, 2017. https://doi.org/10.1016/j.kint.2016.10.036
RethinkPeptides
RethinkPeptides Research Database. "The mitochondrial-targeted peptide, SS-31, improves glomerul..." RPEP-03487. Retrieved from https://rethinkpeptides.com/research/sweetwyne-2017-the-mitochondrialtargeted-peptide-ss31
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.